🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Researchers are evaluating the safety and effectiveness of a single adminis...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2019-10-30
Trial ID
NCT04176133
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
This is a randomized, double blind, placebo-controlled, single site, trial ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2021-09-27
Trial ID
NCT04966871
Treatments Being Tested
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00452790
Treatments Being Tested
The present trial will evaluate safety and tolerability as well as the vacc...
Status
Completed
Location
Bagamoyo Research and Training center of the Ifakara Health Institute
Start Date
2015-12
Trial ID
NCT02613520
Treatments Being Tested